Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biomark Diagnostics Inc (BUX.CN)

Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioMark Announces Warrant Extension and Granting of Options

Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company with...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
BioMark to Advance Development of Cancer Treatment for Glioblastoma

The Company secured collaborative research funding from Research Manitoba and Mitacs for an animal proof-of-concept study.Vancouver, British Columbia--(Newsfile Corp. - April 9, 2024) - BioMark Diagnostics...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities

Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
Theresa Peterson Joins Biomark's Advisory Team

Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced-stage liquid biopsy company with a focus on...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement

Vancouver, British Columbia--(Newsfile Corp. - December 29, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company"), an advanced stage liquid biopsy company...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") a clinical and diagnostic laboratory developing...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term

Vancouver, British Columbia--(Newsfile Corp. - November 28, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark" or the "Company") an advanced stage liquid biopsy company...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives

Dr. W. Randolph Ford, Ph.D., will be joining BioMark's Advisory team to support Artificial Intelligence and Machine Learning capabilities.Vancouver, British Columbia--(Newsfile Corp. - November 14, 2023)...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test

Vancouver, British Columbia and Quebec City, Quebec--(Newsfile Corp. - November 7, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") a leading liquid biopsy company focusing...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)
BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium

Analyses from a retrospective study of early breast cancer metabolomics panel further demonstrate the diagnostic power of BioMark's liquid biopsy platform beyond early lung cancer detection.Vancouver,...

BMKDF : 0.2300 (+2.27%)
BUX.CN : 0.2800 (unch)

Barchart Exclusives

2 Small-Cap Stocks With 40% to 60% Upside
Wall Street believes these two growth stocks will soar, driven by the demand for their products. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar